MoneyWorks4Me

Lupin - Quaterly Results

09 Nov 2022 Evaluate
Revenue reduced marginally to stand at Rs. 28289.60 millions during the quarter ended September 2022. The figure stood at Rs. 28701.70 millions during the year-ago period.The Total Profit for the quarter ended September 2022 of Rs. 1486.20 millions grew from Rs.-13291.20 millions Operating profit Margin for the quarter ended September 2022 improved to 3290.30% as compared to -13242.70% of corresponding quarter ended September 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 28289.60 28701.70 -1.44 55614.50 61842.90 -10.07 117716.70 110559.30 6.47
Other Income 153.70 746.80 -79.42 1006.80 1263.60 -20.32 2169.90 1290.90 68.09
PBIDT 3290.30 -13242.70 -124.85 6242.10 -3347.20 -286.49 4261.30 21731.50 -80.39
Interest 183.80 182.60 0.66 382.50 330.80 15.63 734.70 406.20 80.87
PBDT 3106.50 -13425.30 -123.14 5859.60 -3678.00 -259.31 3526.60 21325.30 -83.46
Depreciation 1377.60 1299.00 6.05 2681.10 2552.60 5.03 5141.90 5028.30 2.26
PBT 1728.90 -14724.30 -111.74 3178.50 -6230.60 -151.01 -1615.30 16297.00 -109.91
TAX 242.70 -1433.10 -116.94 520.50 601.90 -13.52 271.70 3710.80 -92.68
Deferred Tax -45.00 1760.30 -102.56 -56.60 1729.70 -103.27 -306.30 82.30 -472.17
PAT 1486.20 -13291.20 -111.18 2658.00 -6832.50 -138.90 -1887.00 12586.20 -114.99
Equity 909.40 908.10 0.14 909.40 908.10 0.14 909.00 907.40 0.18
PBIDTM(%) 11.63 -46.14 -125.21 11.22 -5.41 -307.37 3.62 19.66 -81.58
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..